Dosing underway in Rain Therapeutics' mid-stage milademetan trial for advanced solid tumors
20 November 2021 - 12:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From Apr 2024 to May 2024
Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From May 2023 to May 2024